Oncternal Therapeutics Inc. buy melinda
Start price
12.06.17
/
50%
€24.29
Target price
12.06.17
€23.80
Performance (%)
12.97%
End price
12.06.17
€27.44
Summary
This prediction ended on 12.06.17 with a price of €27.44. The prediction had a final performance of 12.97%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oncternal Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % | 45,72 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % | 73,26 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % | 48,77 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % | 55,80 % |
According to melinda what are the pros and cons of Oncternal Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
$
(Zielkurs erreicht)
Stopped prediction by melinda for Oncternal Therapeutics Inc.
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.15
08.11.20
08.11.20
€5.00
08.11.21
08.11.21
-29.28%
09.11.21
09.11.21
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.16
16.11.18
16.11.18
€18.94
30.10.19
30.10.19
0.00%
30.10.19
30.10.19
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.24
22.09.18
22.09.18
€22.10
16.11.18
16.11.18
-18.54%
16.11.18
16.11.18
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.12
25.06.17
25.06.17
€34.73
29.06.17
29.06.17
20.34%
29.06.17
29.06.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.91
12.06.17
12.06.17
€21.47
12.06.17
12.06.17
12.97%
12.06.17
12.06.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.91
14.04.17
14.04.17
€31.57
05.05.17
05.05.17
4.54%
05.05.17
05.05.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€140.70
17.11.10
17.11.10
€210.00
17.05.11
17.05.11
104.98%
17.05.11
17.05.11
Could be worthwhile Investment >10% per year


